Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
09/2008
09/24/2008CN101273013A Sulfonamide derivative having PGD2 receptor antagonistic activity
09/24/2008CN101273012A Sythesis of renin inhibitors involving a cycloaddition reaction
09/24/2008CN101270070A Method for preparing (S)-alpha-ethyl-2-oxo--1-pyrrolidine ethanamide with high optical purity
09/24/2008CN100420671C Maleimide derivative and its preparation method and uses
09/23/2008US7427684 Process for the production of lactams
09/23/2008US7427678 Reacting a derivatized molecule with a support; diels-alder reaction; fluorescein; diene or dienophile
09/23/2008US7427612 Such as 1-(4-{4-[2-(cyclopropylmethyl-amino)-5-nitro-benzoyl]-piperazin-1-yl}-3-fluoro- phenyl)-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease
09/23/2008US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic
09/23/2008CA2420952C A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)-1-methylethyl pentanoate
09/23/2008CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors
09/23/2008CA2378382C Carboxylic acid amides, pharmaceutical compositions containing these compounds, the use and preparation thereof
09/23/2008CA2310055C New urethanes, the thio and dithio analogues thereof,the salts thereof, pharmaceutical compositions containing these compounds and their use as well as process for preparing them
09/18/2008WO2008109994A1 Inhibitors of histone deacetylase
09/18/2008WO2008089487A3 Carboxyethylpyrrole compounds and methods of their production
09/18/2008WO2008012231A3 Use of 1,5-dimethylpyrrolidone
09/18/2008US20080227988 Crystallisation and Purification of Glycopyrronium Bromide
09/18/2008US20080227847 (S)-2-hydro-2,6-diaminohexanal-(E)-methoxy-4-oxobut-2-enoate(lysine monomethylfumarate); treatment of e.g. psoriasis or other hyperproliferative, inflammatory or autoimmune disorders
09/18/2008US20080227826 Such as (S)-2-(Dimethylamino)ethyl-1-(4-(2-aminophenylcarbamoyl)-phenyl)pyrrolidin-3-ylcarbamate for treating cell proliferative disorders
09/18/2008US20080227814 Ethanolamine derivatives such as 6-hydroxy-1-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-(p-methylsulfonylphenyl)tetralin and 6-hydroxy-2-(p-(trifluoromethyl)phenyl)-3-(p-(2-(1-piperidinyl)ethoxy)benzoyl)benzothiophene; treating endometriosis and uterine leiomyoma.
09/18/2008US20080227742 Photocleavable oligonucleotide and uses thereof
09/18/2008US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal
09/18/2008CA2680467A1 Inhibitors of histone deacetylase
09/17/2008EP1968935A1 Substituted bis(hetero)aromatic n-ethylpropiolamides and use thereof for production of medicaments
09/17/2008EP1791825B1 Benzoyl-substituted serine amides
09/17/2008EP1392639B1 Pyruvate derivatives
09/17/2008EP1325910B1 Aliphatic nitrogenous five-membered ring compounds
09/17/2008CN101268080A A new route to formyl-porphyrins
09/17/2008CN101268070A Novel sulphonylpyrroles as inhibitors of HDAC novel sulphonylpyrroles
09/17/2008CN101268047A Crystalline and amorphous sodium atorvastatin
09/17/2008CN101268046A Carboxamide derivatives as muscarinic receptor antagonists
09/17/2008CN101268041A Sulphonamide derivatives
09/17/2008CN100418952C Biphenyl derivatives and their use as fungicides
09/17/2008CN100418951C Cycloamine derivative and its use as medicine
09/17/2008CN100418525C Proline derivatives having affinity for the calcium channel alpha-2-delta subunit
09/16/2008US7425642 Anti-diabetic activity, improves insulin resistance and control the blood glucose level more safely, simulates activity of peroxisome proliferator-activated receptor; (1-{(2E)-3-[3-(Bromomethyl)phenyl]prop-2-en-1-yl}-1H-pyrrol-2-yl)(4-methyl-phenyl)methanone
09/16/2008US7425641 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions
09/16/2008US7425633 (3S,5S)-5-(pyrrolidine-1-carbonyl)-N-((1S,2R)-2-(3-(trifluoromethyl)phenyl)cyclopropyl)pyrrolidine-3-carboxamide; inhibiting dipeptidyl peptidase IV or for treating Type II diabetes
09/16/2008US7425631 Compounds and methods of use
09/16/2008US7425576 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis
09/16/2008US7425555 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
09/16/2008US7425554 1,2-di(cyclic)substituted benzene compounds
09/12/2008WO2008109740A2 Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
09/12/2008WO2008108572A1 Novel crystal forms of pyrrolylheptanoic acid derivatives
09/12/2008WO2008073461A3 Ion channel modulators
09/12/2008CA2680133A1 Methods and intermediates for synthesis of selective dpp-iv inhibitors
09/12/2008CA2679564A1 Aryl sulfonamides useful for modulation of the progesterone receptor
09/12/2008CA2679317A1 Novel crystal forms of pyrrolylheptanoic acid derivatives
09/11/2008US20080221334 Process for the Preparation of Onium Alkylsulfonates
09/11/2008US20080221325 And sulfonated poly(aryl ether ketone) monomers; crosslinked with barbituric acid; fuel cells, seawater desalination, heavy water and sewage treatment and biomass-energy resources; improved water holding capacity, chemical resistance, electrochemical stability and heat resistance
09/11/2008US20080221322 Chemical process
09/11/2008US20080221201 4-(5-cyano-1-methyl-1H-pyrrol-2-yl)-N-methylbenzenesulfonamide; contraception, treating or preventing fibroids, uterine leiomyomata, endometriosis, dysfunctional bleeding, polycystic ovary syndrome, or hormone-dependent carcinomas, providing hormone replacement therapy, stimulating food intake
09/11/2008US20080221181 Compounds for treating tumors
09/11/2008US20080221151 In which the amino is substituted by arylmethyl- or heteroarylmethyl- group, e.g., 2-Methoxybenzyl)-(2-phenylpyrrolidin-3-yl)-amine and 5-{[2-(3-Chloro-phenyl)-pyrrolidin-3-ylamino]-methyl}-6-methoxy-3-methyl-1,1a,3,7b-tetrahydro-3-aza-cyclopropa[a]naphalen-2-one; neurokinin 1 (Substance P) inhititors
09/11/2008US20080220973 pesticides and/or herbicides; secondly, a crop plant tolerance promoter compound, which combinations can be used with particularly good results for the selective control of weeds in various crops of useful plants
09/11/2008US20080217580 Organic Luminescent Element
09/11/2008DE102007060033A1 Aminsalzverbindung einer Carbonsäure mit Wärmedissoziationsteil, sowie Kompoundierungsmittel für die Kautschukvulkanisation und Kautschukzusammensetzung, die selbige enthalten Amine salt compound of a carboxylic acid with Wärmedissoziationsteil, and compounding agent for rubber vulcanization and the rubber composition containing selbige
09/10/2008EP1966133A2 Crystal form of atorvastatin hemi-calcium and processes for preparation thereof
09/10/2008EP1966132A2 Compounds which modulate the cb2 receptor
09/10/2008EP1966130A2 Modified lysine-mimetic compounds
09/10/2008EP1474440B1 Coniosulphides and their derivatives, method for their production and use as medicaments
09/10/2008EP1323710B1 Nitrogenous five-membered ring compounds
09/10/2008CN101263156A Novel macrocyclic inhibitors of hepatitis C virus replication
09/10/2008CN101263114A Crystalline and amorphous sodium atorvastatin
09/10/2008CN101263113A 4-substituted pyrrolidin-2-ones and their use
09/10/2008CN101263112A Histamine H3 receptor agents, preparation and therapeutic uses
09/10/2008CN101260072A Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation
09/09/2008US7423177 Carboxamide derivatives as therapeutic agents
09/09/2008US7423176 Bicyclic aromatic sulfinyl derivatives
09/09/2008US7423161 Dithiocarboxylates, dithiocarbonates and trithiocarbonates in which the ester group is 1-substituted with a hydroxy, ether, amine or halo group, e.g., 1-(N-acetylamino)-2,2,2-trifluoroethyl]-O-ethyl dithiocarbonate and 1-ethoxythiocarbonylsulphanyl-2,2,2-trifluoro-ethyl ester of benzoic acid
09/09/2008US7423160 Boron complexation strategy for use in manipulating 1-acyldipyrromethanes
09/09/2008US7423155 (Meth)acrylates, e.g., 2-(p-(succinimidyl)sulfonyl)benzoyloxy)ethyl methacrylate; used for immobilization of amine-containing materials such as amino acidss, peptides, proteins, enzymes, immunoglobulins, DNA, RNA to substrate surfaces
09/09/2008US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists
09/09/2008US7423059 Pharmaceutically active compounds and methods of use
09/09/2008US7423058 Inhibitors of hepatitis C virus NS3 protease
09/09/2008US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid
09/09/2008CA2508871C Crystalline form f of atorvastatin hemi-calcium salt
09/09/2008CA2252163C D-proline derivatives
09/04/2008WO2008105408A1 Novel pyrrole derivative having ureide group and aminocarbonyl group as substituents
09/04/2008WO2008089485A3 Carboxyethylpyrrole compounds and methods of their production
09/04/2008WO2008062279A3 An improved process for the preparation of carbapenem antibiotic
09/04/2008WO2008042755A3 Inhibitors of cognitive decline
09/04/2008US20080214837 Synthetic Method of Optically Pure (S)-3-Hydroxypyrrolidine
09/04/2008US20080214836 Beckmann rearrangement in the gas phase at a temperature of between 180 and 450 degrees C with zeolite catalyst
09/04/2008US20080214651 Administering Atorvastatin; purer, more stable, more advantageous manufacturing properties than the amorphous product
09/04/2008US20080214650 crystalline polymorphic dosage forms of anticholesterol agents; statins; small particle size distribution
09/04/2008US20080214648 Hiv Prodrugs Cleavable by Cd26
09/04/2008US20080214646 Novel Nsaids Possessing a Nitric Oxide Donor Diazen-1-Ium-1,2-Diolate Moiety
09/04/2008US20080214621 Metabolic disorders; antidiabetic agents; obesity; hypotensive agents; antilipemic agents; 1-Cyclohexyl-3-naphthalen-2-ylmethyl-pyrrolidin-2-one
09/04/2008US20080214532 Carboxanilides as Microbiocides
09/04/2008US20080210907 Gelling agent, carbon nanotubes aqueous dispersing agent; simple synthesis from low cost, readily available raw materials; rapid elastic modulus recovery; environmentally friendly
09/04/2008US20080210858 High Stability Polyionic Liquid Salts
09/04/2008CA2678735A1 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents
09/03/2008EP1963406A1 Process for cross-linking copolymers using a sulfur-containing co-agent
09/03/2008EP1963263A1 POLYMORPHS OF [R-(R*, R*)]-2-(4-FLUOROPHENYL)- BETA,DELTA -DIHYDROXY-5-(L-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-lH-PYRROLE-l-HEPTANOIC ACID MAGNESIUM SALT (2: 1)
09/03/2008EP1963262A2 N-hydroxyamide derivatives possessing antibacterial activity
09/03/2008EP1963261A1 Biaryl substituted nitrogen containing heterocycle inhibitors of lta4h for treating inflammation
09/03/2008EP1962984A1 Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound
09/03/2008EP1311480B1 New amidino derivatives and their use as thrombin inhibitors
09/03/2008CN100415801C Polyethylene glycol amino acid N-internal ring carbonyl anhydride active derivatives, and medicinal bonding compound and gel thereof
09/03/2008CN100415750C Fungicides for the control of take-all disease of plants